<code id='857C09DCDE'></code><style id='857C09DCDE'></style>
    • <acronym id='857C09DCDE'></acronym>
      <center id='857C09DCDE'><center id='857C09DCDE'><tfoot id='857C09DCDE'></tfoot></center><abbr id='857C09DCDE'><dir id='857C09DCDE'><tfoot id='857C09DCDE'></tfoot><noframes id='857C09DCDE'>

    • <optgroup id='857C09DCDE'><strike id='857C09DCDE'><sup id='857C09DCDE'></sup></strike><code id='857C09DCDE'></code></optgroup>
        1. <b id='857C09DCDE'><label id='857C09DCDE'><select id='857C09DCDE'><dt id='857C09DCDE'><span id='857C09DCDE'></span></dt></select></label></b><u id='857C09DCDE'></u>
          <i id='857C09DCDE'><strike id='857C09DCDE'><tt id='857C09DCDE'><pre id='857C09DCDE'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:3
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          The cancer stories no one wants to hear
          The cancer stories no one wants to hear

          KARL-JOSEFHILDENBRAND/AFP/GettyImagesDuringthe11monthswhenmyhusband,Ahmad,wasdyingofbladdercancer,fe

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

          OutgoingBristolCEOGiovanniCaforioEmiliePickeringforSTATIt’schangingoftheguardtimeatpharmaceuticalgia